oasis semaglutide Oral 25 mg Demonstrates Substantial Weight Loss in Adults with Overweight or Obesity: Results from The first GLP-1 weight-loss pill:
Description
While these medications have become increasingly popular, their impact on mood and other psychiatric manifestations remains uncertain because of inconsistent data

Clinical trial, 48 weeks: Body weight: -24.2% average Fat loss: significant Lean muscle mass: PRESERVED Metabolic markers: dramatically improved Heres why this is different: Ozempic/Mounjaro = dual agonists (GLP-1 + GIP) Suppress appetite You eat less Lose weight but also muscle Retatrutide = adds glucagon receptor Suppresses appetite AND Activates fat burning directly Body uses fat for fuel instead of breaking down muscle Blood work improvements tracked in trials: Fasting glucose: normalized Triglycerides: -40% Inflammatory markers: reduced Insulin sensitivity: significantly improved The metabolic difference: Dual agonists: Force you to eat less (suffer through hunger, lose muscle) Retatrutide: Reprograms metabolism to PREFER burning fat (appetite controlled, muscle preserved) DEXA scans in the study confirmed: Fat mass dropped dramatically

[14] Cheng, J.-R., Zheng, J., Li, Y., Shi, H., Yang, N., Lei, Y., Wan, Y.-F

Some individuals experience dramatic appetite suppression and rapid weight loss

In head-to-head trials, tirzepatide produced substantially greater weight loss than semaglutide at comparable doses

Individuals who do not take in enough water can become dehydrated and suffer injuries from that too, including organ damage, damage to eyesight, and other complications that come with dehydration
